It’s a long-overdue move by the company, whose board was made up of more well-connected VIPs than scientific experts. In an attempt to regain its reputation after months of controversy and layoffs, blood-testing startup Theranos is appointing an advisory board of pharmaceutical and medical device experts to work alongside its scientific advisors.